Page 193 - CW E-Magazine (24-10-2023)
P. 193

For your requirement of                                                          Special Report
 Acetone
 Benzene
 Toluene  Lipid technology for delivery of gene-editing therapies
 Chloroform
 Soya Lecithin  ene-editing technology is mov-                             STEPHEN BURGESS, Ph.D.
             ing from the research lab to the
 I.P.A.  Gclinic – one of the most eagerly                                 Croda Pharma
 Methyl Salicylate I.P.  anticipated biopharma developments               Further improvements are anticipated
 Ortho & Mix Xylene  in recent history. One of the biggest                as  candidates move through preclini-
       hurdles to the development of success-                             cal and clinical development and more
 Contact:  ful gene-editing therapeutics  is effec-                       knowledge is gained.
 Pure Solvi-Chem India  tive delivery of the large and sensitive

 297-B, Old Post Offi ce Lane, Mangaldas Market,  components needed to execute the editing   A number of companies that have
 Bldg. No. 3-D Mangaldas Road, Mumbai 400 002.
 Tel.: 022-22019080 / 22014846 * Fax: 022-22014846  functions. Lipid-based nanoparticles   been exploring this approach are cur-
 email:  info@puresolvichem.com  present promising solutions to these   phenotype by introducing the gene for  rently seeing rapid acceleration of
 Website: www.puresolvichem.com
       challenges.                       a functional protein.  Today, however,  their programs. For instance,  Verve
                                         many therapeutic candidates based  Therapeutics and Intellia Therapeutics
 Manufacturers of:  The potential of therapeutic CRISPR   on  gene-editing technologies are  now  have begun clinical trials. Many new
 Saccharin Insoluble
 Sodium Saccharin  gene-editing          advancing through the clinic.    companies are entering the space as
 Sodium Saccharin Powder 6%  Gene-editing technologies are                well, quite a number of them focused
 Ortho Toluene Sulphonamide  used to manipulate DNA and RNA   The developers of the fi rst version  on  in vivo therapies. As gene-editing
 Ortho Para Toluene Sulphonamide  sequences by cutting, inserting, or replac-  of CRISPR/Cas9 gene-editing  tech-  systems are optimized and become
 Para Toluene Sulphonyl Chloride  ing  genetic  sequences  in  the  genome.   nology received the 2020 Nobel Prize  more precise and effi cient, the ability
 Para Toluene Sulphonamide  Three primary technologies have been   in Chemistry for their work. A host of  to address new and different diseases
       developed to date: zinc fi nger nuclease   advances have been made since the  will become possible, and there will
 ®
       (ZNF); transcription activator-like   original CRISPR editing tools were  be continued movement toward in vivo
       effector  nuclease (TALEN); and clus-  introduced  – primarily  via  genetic  therapeutics.
 SWATI PETRO PRODUCTS PRIVATE LIMITED  tered regularly interspaced short palin-  engineering – with some of the current
 (Regd. Off.) Plot No B-18, Chemical Zone, MIDC,
 & Unit 1: Ambernath (W) - 421501  dromic  repeat  (CRISPR)(1). Initially,   candidates leveraging second-gene-  Two CRISPR-Cas9 components to
    Tel: +91-251-2682581, 2684285, 7276422244, 8446053566  this  technology was primarily  used   ration technology and others relying  deliver
 Unit 2: Plot No. 15,16&21/9, Morivali, MIDC,
    Ambernath (W) 421501  for research purposes to identify genes   on  third-generation  approaches that   Unlike more traditional gene thera-
    Tel: +91-251-2684286, 8446853565  involved  in disease pathways – either   have addressed some of the earlier  pies that involve delivery of a single
 Unit 3: Plot No. 15,16&21/14, Morivali, MIDC,
    Ambernath (W) 421501  Tel: +91-251-2684287  assessing the consequences of a gene   issues with the precision and persistence  gene of  interest, CRISPR/CRISPR-
 Email: marketing@swatipetro.in, swati.saccharin@gmail.com  knockout/knockdown or  reversing a   required for therapeutic  applications.  associated system (Cas9) gene-editing
 Website: www.swatipetro.in
                                                                          requires co-delivery of the Cas9 endo-
                                                                          nuclease  protein and the single guide
 Industrial Land and shed                                                 RNA (sgRNA)  that targets the editor
 Available on Rent / Sell  /                                              protein to a specifi c genomic location.
 Suitable Business Proposal
                                                                             The  Cas9 protein and sgRNA can
 1. Location - Kurkumbh MIDC                                              be delivered separately or complexed
 2. Area - 12,000 square meter                                            together as a ribonucleoprotein (RNP),
 3. Built up Area - 2790 square                                           which is the active species that per-
 meter                                                                    forms the genome editing  within the
 4. MIDC approval for chemical                                            cell(1). Alternatively, plasmid DNA can
 activity                                                                 be delivered to the cell, where it is tran-
 5. Well connected to Solapur                                             scribed into messenger RNA (mRNA)
 highway                                                                  and then translated into Cas9 protein(2).
                                                                          Another option involves the use of
 Suitable for Factory, Workshop or Godown                                 Cas9 mRNA, which must be translated
 Please Contact:                                                          into Cas9 protein once it is inside the
 Email: directors@halideschemicals.com                                    cell. DNA is more stable than mRNA,
 Mobile: 9921179184, 9881397116
 19/13
       Chemical Weekly  October 24, 2023                                                               193

                                      Contents    Index to Advertisers    Index to Products Advertised
   188   189   190   191   192   193   194   195   196   197   198